| Dokumendiregister | Riigikogu |
| Viit | 1-2/25-972/7 |
| Registreeritud | 19.06.2026 |
| Sünkroonitud | 20.06.2026 |
| Liik | EL dokument |
| Funktsioon | |
| Sari | |
| Toimik | Ettepanek: EUROOPA PARLAMENDI JA NÕUKOGU MÄÄRUS, millega muudetakse määrusi (EL) 2017/745 ja (EL) 2017/746 seoses meditsiiniseadmeid ja in vitro diagnostikameditsiiniseadmeid käsitlevate eeskirjade lihtsustamisega ja neist tuleneva koormuse vähendamisega, määrust (EL) 2022/123 seoses Euroopa Ravimiameti toega meditsiiniseadmete eksperdirühmadele ja määrust (EL) 2024/1689 seoses I lisas osutatud liidu ühtlustamisõigusaktide loeteluga (EMPs kohaldatav tekst) - SWD(2025) 1050-1052, COM(2025) 1023 |
| Juurdepääsupiirang | Avalik |
| Adressaat | |
| Saabumis/saatmisviis | |
| Vastutaja | |
| Originaal | Ava uues aknas |
10876/26
LIFE.5 EN/IT
Council of the European Union
Brussels, 19 June 2026 (OR. en, it)
10876/26
SAN 503 PHARM 114 MI 678 COMPET 807 CODEC 1267 INST 260 PARLNAT 134
PARLNAT
Interinstitutional File: 2025/0404 (COD)
COVER NOTE
From: The Italian Senate
date of receipt: 18 June 2026
To: The President of the Council of the European Union
Subject: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I [16919/25 - 2025/0404(COD)]
- Opinion on the application of the Principles of Subsidiarity and Proportionality
Delegations will find attached the opinion1 of the Italian Senate on the above.
1 The translation(s) of the opinion may be available on the Interparliamentary EU Information Exchange website
(IPEX) at the following address: https://secure.ipex.eu/IPEXL-WEB/document/COM-2025-1023
10876/26 1
LIFE.5 EN/IT
ANNEX
10876/26 2
LIFE.5 EN/IT
10876/26 3
LIFE.5 EN/IT
10876/26 4
LIFE.5 EN/IT
____________________